Learnt at the weekend, REPUBLIC of Madagascar requested Nigeria to pay 170,000 Euros.
Guinea Bissau President visited President Muhammadu Buhari brought the medication allotted to Nigeria by Madagascar.
NAFDAC and NIPRD are awaiting the samples from Madagascar for validation
REPUBLIC of Madagascar requested Nigeria to pay 170,000 Euros. For the amount of its COVID-19 treatment medication despatched to the Federal Government. learnt at the weekend.
The amount of the consignment despatched to Nigeria via Guinea Bissau couldn’t ascertained yesterday.
Guinea Bissau President Umaro Sissoco Embalo, who visited President Muhammadu Buhari at the State House in Abuja on Saturday. Brought the medication allotted to Nigeria by Madagascar.
President Buhari mentioned Nigeria would take the drug through intensive test to find out its suitability.
“For our consignments in Guinea Bissau, Madagascar asked Nigeria to pay over €170,000 (N78, 200,000). Now we acquired the bill as a result of the African country made us to understand that the medication are not given out free.
“We are requested to pay for the medication yet to be validated. Because the AU directed the availability of the medication to African nations. We might have no alternative than to pay for it.
“This fee may, nonetheless, be one-off as a result of mass importation of the medication from Madagascar will not be cost effective. By the point we bear in mind the price of freight, the amount will be too high.
“For this reason we’re taking a look at native choices accessible to us as a nation.
“Some researchers advised us that we’ve got richer herbs to contain COVID-19. The truth is, a store in Wuse 2, Abuja promoting Artemisia Tea. With excessive efficiency than COV drugs.
“As a nation, we’ll leave all options open and look inwards. However, we’ll subject Madagascar natural medication to verification or validation.
“The Presidential Task Force (PTF) on COVID-19. Also, pondering of asking the National Company for Food and Drug Administration and Control (NAFDAC) and the National Institute for Pharmaceutical Research and Development (NIPRD) to loosen up the protocols. To hasten the validation of local medication for COVID-19.:
A highly-placed supply in NIPRD mentioned: “We’re but to get the samples for testing and validation. We’re hopeful that this week, we’d obtain them. Our team is on the alert.”
The Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC), Prof Mojisola Adeyeye. Mentioned many researchers and practitioners responded to its call for expression of interest for the COVID-19 associated medicines.
In an announcement on NAFDAC website, Adeyeye mentioned: “The National Agency for Food and Drug Administration and Control (NAFDAC). As on the time of this press release, has only received application from one firm. For a product the company is presenting (for approval) to the Agency for the treatment of the symptoms of Covid-19. Not for the cure of Covid-19 as a disease.
“Call for expression of interest for the COVID-19 related medicines made; a number of researchers and practitioners responded and guided to submit such medicines to NAFDAC for expedited assessment.
The company continues to encourage all stakeholders to present the products of their research findings. Allow these remedies undergo internationally recognised process of approval by pre-clinical and where applicable, clinical trials.
“Lastly, because the body with the mandate to regulate the conduct of clinical trials within the nation. NAFDAC is dedicated to encouraging and supporting sponsors with acceptable guidance. To expedite the development of effective interventions to deal with or prevent COVID-19.”
